Incannex Healthcare Inc.
IXHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873875
No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.
Holders of 5% or more of IXHL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Incannex Healthcare Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Incannex Healthcare Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Incannex Healthcare Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20257:28 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 4.99%1.47M shares | −2.01 ppfrom 7.00%Below 5% | Mar 31, 2025 | SEC |
| May 15, 20257:05 PM ET | S.H.N. Financial Investments Ltd. | 13G/A | 0.00%0 shares | −7.00 ppfrom 7.00%Below 5% | Mar 31, 2025 | SEC |
| Mar 14, 20254:21 PM ET | S.H.N. Financial Investments Ltd. | 13G | 7.00%1.93M shares | New | Mar 10, 2025 | SEC |
| Mar 13, 20254:36 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G | 7.00%1.93M shares | New | Mar 10, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Incannex Healthcare Inc. shares.
No Form 144 notices for Incannex Healthcare Inc. are on file.